FDA okays RU486 after years of controversy
By Kate Fodor
NEW YORK, Sep 28 (Reuters Health) - After 4 years of controversy and negotiation, the US Food and Drug Administration (FDA) on Thursday approved the abortion drug mifepristone, more commonly known as RU-486. The approval comes with some, but...